Sign in Subscribe
Cardiac patients

Vitamin D May Influence Disease Course in PIMS-TS/MIS-C: An Observational Cohort Study

Strategic Insights

— 2 min read

Pediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS), a rare and mysterious disease, has been linked to Kawasaki disease in younger patients. Researchers at Oxford University Hospitals NHS Foundation Trust have identified a potential connection between vitamin D levels and the severity of PIMS-TS. The study, published in Pediatrics International, revealed that lower serum vitamin D levels were associated with higher levels of inflammation and longer durations of vasoactive medications.

Key Takeaways:

  • The study retrospectively reviewed 63 patients with PIMS-TS treated in Oxford between May 2020 and May 2022, finding that 51/54 (94.4%) were SARS-CoV-2-antibody positive.
  • Patients requiring vasoactive medications had higher peak NT-pro-BNP levels and longer lengths of stay compared to those not requiring vasoactive medications.
  • Vitamin D levels inversely correlated with peak CRP and duration of vasoactive medications, with lower serum vitamin D levels associated with lower SARS-CoV-2 anti-nucleocapsid titers.
  • Children receiving IV methylprednisolone with or without IVIg had a more rapid fall in CRP compared to those given IVIg alone or no immunomodulatory treatment.
  • No patients had coronary artery aneurysm or persistent cardiac sequelae at discharge.
  • The study demonstrated a relationship between vitamin D, SARS-CoV-2 anti-nucleocapsid antibody production, inflammatory biomarkers, and duration of vasoactive medication.
  • The findings require further validation to determine the role of vitamin D in the disease course of PIMS-TS/MIS-C.
  • The study suggests that vitamin D supplementation may be beneficial for patients with PIMS-TS/MIS-C; however, more research is needed to confirm this.
  • The study underscores the importance of considering vitamin D levels in the management of PIMS-TS/MIS-C.
  • The study highlights the need for further investigation into the relationship between vitamin D and PIMS-TS/MIS-C.
  • The study's findings have the potential to inform clinical practice and improve patient outcomes in PIMS-TS/MIS-C.
  • The study's results support the need for further research on the role of vitamin D in the disease process.
  • The study's conclusion emphasizes the necessity of further validation to establish the relationship between vitamin D and PIMS-TS/MIS-C.

Statistics:

  • 51/54 (94.4%) patients with PIMS-TS were SARS-CoV-2-antibody positive.
  • 63 patients with PIMS-TS were treated in Oxford between May 2020 and May 2022.
  • 40 children (63.5%) required vasoactive medications.
  • Peak NT-pro-BNP levels were higher in patients requiring vasoactive medications (median 11,363 ng/L vs. 3741 ng/L, p = 0.004).
  • Length of stay was longer in patients requiring vasoactive medications (median 8.4 vs. 6.4 days, p = 0.021).
  • Vitamin D levels inversely correlated with peak CRP (spearman r = -0.34, p = 0.007) and duration of vasoactive medications (spearman r = -0.34, p = 0.030).

Sources:

  • NewsRx. Study Findings on COVID-19 Are Outlined in Reports from Oxford University Hospitals NHS Foundation Trust (Vitamin D may influence disease course in PIMS-TS/MIS-C: An observational cohort study). Clinical Trials Week. October 27, 2025; p 289.
  • Vitamin D may influence disease course in PIMS-TS/MIS-C: An observational cohort study. Pediatrics International, 2025;67(1). (Available online at: onlinelibrary.wiley.com/journal/10.1111/(ISSN)1442-200X)
  • Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK. (Contact: Joshua Navarajasegaran, Acute General Medicine)

Read more